Literature DB >> 10902766

Lack of CD80 expression by fibroblast-like synoviocytes leading to anergy in T lymphocytes.

V M Corrigall1, E Solau-Gervais, G S Panayi.   

Abstract

OBJECTIVE: To investigate whether contact with HLA-DR+, but CD80-, fibroblast-like synoviocytes (FLS) in the presence of antigen leads to the induction of anergy in, rather than stimulation of, T cells.
METHODS: Cell surface expression of activation and costimulatory markers on FLS were studied by flow cytometry. Functional changes were investigated by T cell proliferation to tuberculin purified protein derivative or allogeneic responses to FLS, in the presence or absence of DAP3.B7 cells, a human CD80-transfected mouse fibroblast cell line. Induction of anergy was investigated by a 2-stage culture system. T cells were cocultured with allogeneic FLS in the primary culture, rested, and restimulated in the secondary culture by FLS in the presence or absence of DAP3.B7 cells or interleukin-2 (IL-2).
RESULTS: Direct contact between T cells and FLS caused up-regulation of CD69 on T cells and HLA-DR on FLS in both the allogeneic and autologous cultures. The addition of DAP3.B7 cells to FLS-T cell cocultures restored the depressed allogeneic responses of T cells. The allogeneic response by T cells to FLS in the presence of DAP3.B7 cells could be completely inhibited by blocking CD80 with CTLA-4 Ig. Indirect evidence that T cells cocultured with FLS were anergic was the up-regulation of CD25, negligible T cell proliferation, and the restoration of proliferation by the addition of exogenous IL-2. Direct evidence of anergy was obtained when T cells from the primary cultures with FLS remained unresponsive to secondary culture with FLS even in the presence of DAP3.B7 cells. In contrast, primary culture of T cells with FLS plus DAP3.B7 cells initiated a good allogeneic response in all subsequent cultures.
CONCLUSION: It is possible that T cells within the synovium may be anergized by contact with HLA-DR+ CD80- FLS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10902766     DOI: 10.1002/1529-0131(200007)43:7<1606::AID-ANR26>3.0.CO;2-O

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  7 in total

1.  Synovial biology and T cells in rheumatoid arthritis.

Authors:  Chinh N Tran; Steven K Lundy; David A Fox
Journal:  Pathophysiology       Date:  2005-10

2.  Molecular interactions between T cells and fibroblast-like synoviocytes: role of membrane tumor necrosis factor-alpha on cytokine-activated T cells.

Authors:  Chinh N Tran; Steven K Lundy; Peter T White; Judith L Endres; Christopher D Motyl; Raj Gupta; Cailin M Wilke; Eric A Shelden; Kevin C Chung; Andrew G Urquhart; David A Fox
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

3.  Differential survival of leukocyte subsets mediated by synovial, bone marrow, and skin fibroblasts: site-specific versus activation-dependent survival of T cells and neutrophils.

Authors:  Andrew Filer; Greg Parsonage; Emily Smith; Chloe Osborne; Andrew M C Thomas; S John Curnow; G Ed Rainger; Karim Raza; Gerard B Nash; Janet Lord; Mike Salmon; Christopher D Buckley
Journal:  Arthritis Rheum       Date:  2006-07

Review 4.  Are mesenchymal stem cells in rheumatoid arthritis the good or bad guys?

Authors:  Cosimo De Bari
Journal:  Arthritis Res Ther       Date:  2015-05-01       Impact factor: 5.156

Review 5.  Two Main Cellular Components in Rheumatoid Arthritis: Communication Between T Cells and Fibroblast-Like Synoviocytes in the Joint Synovium.

Authors:  Jiajie Tu; Wei Huang; Weiwei Zhang; Jiawei Mei; Chen Zhu
Journal:  Front Immunol       Date:  2022-07-01       Impact factor: 8.786

6.  CTLA-4-Ig internalizes CD80 in fibroblast-like synoviocytes from chronic inflammatory arthritis mouse model.

Authors:  Yoko Miura; Shyuntaro Isogai; Shinji Maeda; Satoshi Kanazawa
Journal:  Sci Rep       Date:  2022-09-30       Impact factor: 4.996

7.  Differential activation of human T cells to allogeneic endothelial cells, epithelial cells and fibroblasts in vitro.

Authors:  Dmitry Samsonov; Christopher Geehan; Craig B Woda; David M Briscoe
Journal:  Transplant Res       Date:  2012-04-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.